Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
patient death
Podcast
Untangling Sarepta’s gene therapy fallout
In this episode of "The Top Line," we break down a whirlwind three weeks for Sarepta Therapeutics.
Ayla Ellison
,
Fraiser Kansteiner
,
Angus Liu
,
Gabrielle Masson
Aug 1, 2025 9:07am
FDA backtracks on Sarepta's gene therapy Elevidys in DMD
Jul 28, 2025 6:02pm
FDA eyeing study requirements to confirm Elevidys safety: report
Jul 24, 2025 3:12pm
Sarepta will continue shipping Elevidys despite FDA misgivings
Jul 21, 2025 10:42am
Fierce Biotech
Sarepta faces new scrutiny after 3rd patient death
Jul 18, 2025 10:19am
Gilead's Trodelvy suffers double whammy
May 30, 2024 6:20pm